,outcome,arm 1,arm 2
0,intervention,active therapy,control group
0,N-telopeptide cross-linked collagen type I,decreased by 19.3 %,NR
0,"N-telopeptide cross-linked collagen type I, N-terminal propeptide of type I procollagen",by 26.6 %,by 26.6 %
